Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP787917.RAtXdJr5KSfDKCj4QU32uFOtl3QQY-JCM7nfgBb7JlfL0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP787917.RAtXdJr5KSfDKCj4QU32uFOtl3QQY-JCM7nfgBb7JlfL0130_assertion type Assertion NP787917.RAtXdJr5KSfDKCj4QU32uFOtl3QQY-JCM7nfgBb7JlfL0130_head.
- NP787917.RAtXdJr5KSfDKCj4QU32uFOtl3QQY-JCM7nfgBb7JlfL0130_assertion description "[In agreement with our molecular analysis, 1) VIP was the most potent peptide among VIP-related peptides (VIP > PACAP > PHM > PHV) to stimulate cAMP production through specific type 1 VIP receptors in both PTEC and LT-TEC; 2) cAMP generation was induced by CGRP in PTEC and by CT in LT-TEC; 3) in frozen thymic sections and by flow cytometry, type 1 VIP-R, CGRP-R, and CT-R were localized in epithelial cells; and 4) in parallel, the transcription of the acetylcholine receptor alpha subunit (the main autoantigen in MG) was induced by CGRP and CT in PTEC and LT-TEC, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787917.RAtXdJr5KSfDKCj4QU32uFOtl3QQY-JCM7nfgBb7JlfL0130_provenance.
- NP787917.RAtXdJr5KSfDKCj4QU32uFOtl3QQY-JCM7nfgBb7JlfL0130_assertion evidence source_evidence_literature NP787917.RAtXdJr5KSfDKCj4QU32uFOtl3QQY-JCM7nfgBb7JlfL0130_provenance.
- NP787917.RAtXdJr5KSfDKCj4QU32uFOtl3QQY-JCM7nfgBb7JlfL0130_assertion SIO_000772 9973484 NP787917.RAtXdJr5KSfDKCj4QU32uFOtl3QQY-JCM7nfgBb7JlfL0130_provenance.
- NP787917.RAtXdJr5KSfDKCj4QU32uFOtl3QQY-JCM7nfgBb7JlfL0130_assertion wasDerivedFrom befree-20150227 NP787917.RAtXdJr5KSfDKCj4QU32uFOtl3QQY-JCM7nfgBb7JlfL0130_provenance.
- NP787917.RAtXdJr5KSfDKCj4QU32uFOtl3QQY-JCM7nfgBb7JlfL0130_assertion wasGeneratedBy ECO_0000203 NP787917.RAtXdJr5KSfDKCj4QU32uFOtl3QQY-JCM7nfgBb7JlfL0130_provenance.